PubMed

Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3.

Stitt AW, McGoldrick C, Rice-McCaldin A, McCance DR, Glenn JV, Hsu DK, Liu FT, Thorpe SR, Gardiner TA.

Diabetes. 2005 Mar;54(3):785-94.PMID: 15734857 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.

Canning P, Glenn JV, Hsu DK, Liu FT, Gardiner TA, Stitt AW.

Exp Diabetes Res. 2007;2007:51837.PMID: 17641742 [PubMed - indexed for MEDLINE]Related articlesFree article

Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration.

de Gooyer TE, Stevenson KA, Humphries P, Simpson DA, Gardiner TA, Stitt AW.

Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5561-8.PMID: 17122149 [PubMed - indexed for MEDLINE]Related articlesFree article

Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.

Shoji T, Koyama H, Morioka T, Tanaka S, Kizu A, Motoyama K, Mori K, Fukumoto S, Shioi A, Shimogaito N, Takeuchi M, Yamamoto Y, Yonekura H, Yamamoto H, Nishizawa Y.

Diabetes. 2006 Aug;55(8):2245-55.PMID: 16873687 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.

Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, Yamamoto Y, Yamamoto H, Adamis AP.

Invest Ophthalmol Vis Sci. 2007 Feb;48(2):858-65.PMID: 17251488 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of advanced glycation end products in retinal microvascular leukostasis.

Moore TC, Moore JE, Kaji Y, Frizzell N, Usui T, Poulaki V, Campbell IL, Stitt AW, Gardiner TA, Archer DB, Adamis AP.

Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4457-64.PMID: 14507893 [PubMed - indexed for MEDLINE]Related articlesFree article

Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy.

Segawa Y, Shirao Y, Yamagishi S, Higashide T, Kobayashi M, Katsuno K, Iyobe A, Harada H, Sato F, Miyata H, Asai H, Nishimura A, Takahira M, Souno T, Segawa Y, Maeda K, Shima K, Mizuno A, Yamamoto H, Kawasaki K.

Ophthalmic Res. 1998;30(6):333-9.PMID: 9731114 [PubMed - indexed for MEDLINE]Related articles

Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor.

Iacobini C, Menini S, Oddi G, Ricci C, Amadio L, Pricci F, Olivieri A, Sorcini M, Di Mario U, Pesce C, Pugliese G.

FASEB J. 2004 Nov;18(14):1773-5. Epub 2004 Sep 10.PMID: 15361471 [PubMed - indexed for MEDLINE]Related articlesFree article

Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.

Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M, Suzuma I, Ohashi H, Ojima T, Murakami T, Kobayashi T, Masuda S, Nagao M, Yoshimura N, Takagi H.

N Engl J Med. 2005 Aug 25;353(8):782-92.PMID: 16120858 [PubMed - indexed for MEDLINE]Related articlesFree article

Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.

Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H.

Am J Pathol. 1997 Feb;150(2):523-31.PMID: 9033268 [PubMed - indexed for MEDLINE]Related articlesFree article

[Molecular mechanism of diabetic retinopathy: role of advanced glycation end products(AGEs) and their receptor (RAGE) in the pathogenesis of diabetic retinopathy]

Yamagishi S, Imaizumi T.

Nippon Ganka Gakkai Zasshi. 2005 Jun;109(6):338-45. Review. Japanese. PMID: 16047941 [PubMed - indexed for MEDLINE]Related articles

Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice.

Tamarat R, Silvestre JS, Huijberts M, Benessiano J, Ebrahimian TG, Duriez M, Wautier MP, Wautier JL, Lévy BI.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8555-60. Epub 2003 Jun 12.PMID: 12805564 [PubMed - indexed for MEDLINE]Related articlesFree article

Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice.

Pugliese G, Pricci F, Iacobini C, Leto G, Amadio L, Barsotti P, Frigeri L, Hsu DK, Vlassara H, Liu FT, Di Mario U.

FASEB J. 2001 Nov;15(13):2471-9.PMID: 11689472 [PubMed - indexed for MEDLINE]Related articlesFree article

Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression.

Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi Y, Yoshida Y, Matsuura T, Narama I, Motomiya Y, Takeuchi M, Inoue H, Yoshimura A, Bucala R, Imaizumi T.

J Biol Chem. 2006 Jul 21;281(29):20213-20. Epub 2006 May 17.PMID: 16707486 [PubMed - indexed for MEDLINE]Related articlesFree article

Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells.

Suganami E, Takagi H, Ohashi H, Suzuma K, Suzuma I, Oh H, Watanabe D, Ojima T, Suganami T, Fujio Y, Nakao K, Ogawa Y, Yoshimura N.

Diabetes. 2004 Sep;53(9):2443-8.PMID: 15331557 [PubMed - indexed for MEDLINE]Related articlesFree article

The RAGE axis in early diabetic retinopathy.

Barile GR, Pachydaki SI, Tari SR, Lee SE, Donmoyer CM, Ma W, Rong LL, Buciarelli LG, Wendt T, Hörig H, Hudson BI, Qu W, Weinberg AD, Yan SF, Schmidt AM.

Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2916-24.PMID: 16043866 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunolocalization and quantification of advanced glycation end products in retinal neovascular membranes and serum: a possible role in ocular neovascularization.

Swamy-Mruthinti S, Miriam KC, Kumar SK, Biswas J, Ramakrishnan S, Nagaraj RH, Sulochana KN.

Curr Eye Res. 2002 Sep;25(3):139-45.PMID: 12607183 [PubMed - indexed for MEDLINE]Related articles

Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice.

Iacobini C, Oddi G, Menini S, Amadio L, Ricci C, Di Pippo C, Sorcini M, Pricci F, Pugliese F, Pugliese G.

Am J Physiol Renal Physiol. 2005 Sep;289(3):F611-21. Epub 2005 May 3.PMID: 15870382 [PubMed - indexed for MEDLINE]Related articlesFree article

Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.

Yamagishi S, Matsui T, Nakamura K, Inoue H, Takeuchi M, Ueda S, Fukami K, Okuda S, Imaizumi T.

Microvasc Res. 2008 Jan;75(1):130-4. Epub 2007 May 18.PMID: 17560613 [PubMed - indexed for MEDLINE]Related articles

Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.

Gardiner TA, Anderson HR, Stitt AW.

J Pathol. 2003 Oct;201(2):328-33.PMID: 14517851 [PubMed - indexed for MEDLINE]Related articles